Catalyst Pharmaceuticals Inc (CPRX)
21.48
+0.36
(+1.70%)
USD |
NASDAQ |
Nov 22, 16:00
21.47
-0.01
(-0.05%)
After-Hours: 20:00
Catalyst Pharmaceuticals Cash from Financing (Quarterly): -5.974M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -5.974M |
| June 30, 2024 | 1.157M |
| March 31, 2024 | 141.05M |
| December 31, 2023 | -0.665M |
| September 30, 2023 | -10.13M |
| June 30, 2023 | -0.214M |
| March 31, 2023 | 0.149M |
| December 31, 2022 | 2.253M |
| September 30, 2022 | 3.984M |
| June 30, 2022 | -2.992M |
| March 31, 2022 | -1.551M |
| December 31, 2021 | -2.526M |
| September 30, 2021 | -2.098M |
| June 30, 2021 | -3.707M |
| March 31, 2021 | 0.188M |
| December 31, 2020 | 0.026M |
| September 30, 2020 | 0.614M |
| June 30, 2020 | 0.036M |
| March 31, 2020 | 0.026M |
| December 31, 2019 | 0.578M |
| September 30, 2019 | 0.2561M |
| June 30, 2019 | 0.1925M |
| March 31, 2019 | 0.0893M |
| December 31, 2018 | 0.1515M |
| September 30, 2018 | 0.1045M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.0041M |
| March 31, 2018 | 0.033M |
| December 31, 2017 | 54.14M |
| September 30, 2017 | 1.408M |
| June 30, 2017 | 1.805M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.0803M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.0113M |
| December 31, 2015 | 0.0654M |
| September 30, 2015 | 0.9166M |
| June 30, 2015 | 0.113M |
| March 31, 2015 | 36.06M |
| December 31, 2014 | 1.822M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 26.73M |
| March 31, 2014 | 0.0165M |
| December 31, 2013 | 0.1898M |
| September 30, 2013 | 17.97M |
| June 30, 2013 | 0.0235M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 5.083M |
| September 30, 2012 | 5.56M |
| June 30, 2012 | 3.938M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-10.13M
Minimum
Sep 2023
141.05M
Maximum
Mar 2024
6.010M
Average
0.026M
Median
Mar 2020
Cash from Financing (Quarterly) Benchmarks
| Corcept Therapeutics Inc | -21.09M |
| Vertex Pharmaceuticals Inc | -387.50M |
| Sarepta Therapeutics Inc | 13.76M |
| ADMA Biologics Inc | -25.47M |
| BioVie Inc | -0.2409M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 72.87M |
| Cash from Investing (Quarterly) | -0.259M |
| Free Cash Flow | 221.79M |
| Free Cash Flow Per Share (Quarterly) | 0.579 |
| Free Cash Flow to Equity (Quarterly) | 72.61M |
| Free Cash Flow to Firm (Quarterly) | 72.61M |
| Free Cash Flow Yield | 8.48% |